Withdraw due to duplicate registration. Efficacy of different analgesic regimens in the treatment of pain after arthroscopic shoulder surgery: a randomized controlled study

Efficacy of different analgesic regimens in the treatment of pain after arthroscopic shoulder surgery: a randomized controlled study

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200061059

Enrollment

Unknown

Registered

2022-06-15

Start date

2022-06-01

Completion date

Unknown

Last updated

2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

shoulder disease

Interventions

experience group:The experimental group received single supraclavicular brachial plexus block with ropivacaine 0.375% 23ml + dexmedetomidine 50ug + 250mg MgSO4

control group:Intravenous infusion of 100ml saline, single supraclavicular brachial plexus block with ropivacaine 0.375% 25ml

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years; 2. BMI 18-26; 3. ASA level 1-3; 4. Patients who intend to undergo unilateral shoulder arthroscopy; 5. Agree to accept this study.

Exclusion criteria

Exclusion criteria: 1. Allergic to related narcotic drugs; 2. Contraindications of brachial plexus block, such as coagulation dysfunction and local infection; 3. Patients with slow pain and long-term use of analgesics before operation; 4. Patients with cognitive impairment and unable to cooperate with postoperative pain assessment; 5. Pregnant and diabetes patients; 6. Patients with liver and kidney dysfunction.

Design outcomes

Primary

Measure	Time frame
Pain score;	—

Countries

China

Contacts

Public ContactNie Mao

The Second Affiliated Hospital of Chongqing Medical University

xiaomao023@126.com+86 13678428205

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026